Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
Where
Shanghai
Age
18 years and over
People
50
Run by
HC Biopharma Inc.
See details and how to joinNCT07169552
No phaseNot yet taking people in China
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
Where
Wuhan
Age
18 years to 80 years
People
1,000
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07287904
Phase 2Not yet taking people in China
Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial
Where
Nanjing
Age
18 years to 75 years
People
24
Run by
Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07286942
Phase 3Taking people
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
Where
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xi’an, Xuzhou, Zhengzhou
Age
18 years and over
People
360
Run by
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
See details and how to joinNCT07182682
Phase 2Taking people
A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Hangzhou, Shanghai
Age
18 years to 75 years
People
100
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07232849
Phase 1Taking people
A Study of GC203 TIL in Advanced Malignant Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
18
Run by
Shanghai Juncell Therapeutics
See details and how to joinNCT06375187
No phaseNot yet taking people in China
The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy
Where
Shanghai
Age
18 years to 80 years
People
158
Run by
Jiayuan Sun
See details and how to joinNCT07277088
Phase 1/2Taking people
LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
Where
Beijing
Age
18 years and over
People
60
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05886439
Phase 2Taking people
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
15
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06758700
Phase 1/2Taking people
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Where
Zhengzhou
Age
18 years to 70 years
People
42
Run by
Henan Cancer Hospital
See details and how to joinNCT07264569
Phase 1/2Taking people
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Where
Beijing, Shanghai
Age
18 years and over
People
350
Run by
GV20 Therapeutics
See details and how to joinNCT07070518
Phase 1Taking people
VSV-02 Compassionate Use in Advanced Solid Tumors
Where
Xinxiang
Age
18 years and over
People
6
Run by
The First Affiliated Hospital of Xinxiang Medical College
See details and how to joinNCT07260591
Phase 2Taking people
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
Where
Beijing
Age
18 years and over
People
18
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05751018
Phase 1/2Taking people
Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
Where
Jinan
Age
18 years and over
People
156
Run by
Mainline Biosciences (Shanghai) Co., Ltd
See details and how to joinNCT06840821
No phaseTaking people
RAPART in Locally Advanced Non-small Cell Lung Cancer Patients
Where
Shenzhen
Age
18 years and over
People
911
Run by
Capital Medical University
See details and how to joinNCT07164885
No phaseTaking people
Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
Where
Beijing
Age
18 years to 85 years
People
30
Run by
Beijing Haidian Hospital
See details and how to joinNCT07257458
No phaseTaking people
Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
Where
Beijing
Age
18 years to 85 years
People
30
Run by
Beijing Haidian Hospital
See details and how to joinNCT07257471
Phase 2Taking people
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Where
Guangzhou
Age
18 years to 70 years
People
300
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT07229729
No phaseTaking people
The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
Where
Changsha, Wuhan
Age
18 years to 75 years
People
40
Run by
Fang Wu
See details and how to joinNCT05113017
Phase 2Taking people
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
Where
Shanghai
Age
18 years and over
People
250
Run by
Shanghai Chest Hospital
See details and how to joinNCT07058519
Phase 1Taking people
A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
Where
Hangzhou
Age
18 years and over
People
48
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07250386
No phaseTaking people
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Where
Beijing
Age
18 years and over
People
150
Run by
Peking Union Medical College
See details and how to joinNCT07247227
No phaseTaking people
Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy
Where
Harbin
Age
18 years to 75 years
People
200
Run by
Beidahuang Industry Group General Hospital
See details and how to joinNCT06776588
Phase 1Taking people
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
Where
Chengdu
Age
18 years and over
People
10
Run by
West China Hospital
See details and how to joinNCT07106827
Phase 1Taking people
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
Where
Guangzhou
Age
18 years and over
People
33
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07232420